1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Health-Chem Corporation

Health-Chem Corporation

HCLC
Health-Chem CorporationUS flagOther OTC
0.00
USD
- -
- -
73,985.00Market Cap
1988 Y
1989 Y
1990 Y
1991 Y
1992 Y
1993 Y
1994 Y
1995 Y
1996 Y
1997 Y
2004 Y
2005 Y
2006 Y
TTM
Revenue per Share
5.4
3.73
5.38
4.45
7.13
5.65
6.03
6.2
6.22
4.68
0.8
0.66
0.52
5.35
Basic EPS, GAAP
0.21
-0.15
-1.17
0.06
0.35
0.34
0.18
-0.04
-0.17
-0.41
- -
-0.22
-0.14
-0.51
Free Cash Flow per Basic Share
- -
- -
- -
0.11
0.04
0.29
-0.1
-0.36
0.03
-0.26
0.02
-0.03
0.03
-0.17
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.1
- -
-1.13
-0.97
-1.01
-0.4
-0.24
-0.28
-0.46
-0.83
-2.07
-2.29
-2.44
-1.35
Tangible Book Value per Share
1.47
0.76
- -
0.16
0.74
0.68
1.02
1.04
0.84
0.4
-1.08
-1.3
-1.45
0.19
Basic Weighted Avg Shares
7
11
7
8
5
8
8
8
8
8
11
11
11
7
Sales/Revenue/Turnover
36
42
38
37
39
45
47
46
48
38
9
8
6
37
Operating Margin (%)
-0.56
-1.65
-6.54
-2.16
-0.52
6.01
6.18
0.86
-2.94
-9.02
9.62
-25.47
-30.96
-7.34
Depreciation Expense
1
2
2
2
2
2
2
2
2
2
- -
- -
- -
3
Net Income, GAAP
1
-2
-8
- -
2
3
1
- -
-1
-3
- -
-2
-2
-4
Effective Tax Rate (%)
- -
- -
- -
28.57
- -
- -
36.36
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
3.89
-4.02
-21.73
1.35
4.91
6.01
2.99
-0.65
-2.73
-8.75
0.1
-32.69
-27.88
-9.51
Working Capital
16
13
9
6
9
7
8
9
7
6
-12
-15
-16
-11
LT Debt
20
22
30
24
18
14
14
17
16
16
- -
2
1
- -
Total Equity
11
10
1
2
5
6
9
8
7
4
-12
-15
-17
1
Return on Invested Capital (%)
- -
- -
- -
-1.99
- -
- -
8.52
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
2.64
- -
- -
12.02
- -
- -
- -
-23.71
- -
- -
- -
Return on Common Equity (%)
- -
-485.71
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'04
Jun'04
Sep'04
ST Debt
- -
- -
18
LT Borrowings
17
9
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
4
13
9

Working Capital

FRC

•

in mil. unless spec.
Mar'04
Jun'04
Sep'04
Total Current Assets
15
14
14
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
8
8
8
Total Current Liabilities
8
15
25
Payables & Accruals
4
4
5
ST Debt
- -
- -
18
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-19.95%
-89.05%
11.08%
Free Cash Flow
- -
-363.45%
-216.33%
Net Income, GAAP
-2,725.54%
-5,460.38%
-33.23%
Sales/Revenue/Turnover
-11.22%
-26.64%
-21.7%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
- -
- -
- -
- -
8
2006
2
1
- -
- -
6
2007
1
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
- -
- -
- -
- -
-0.22
2006
-0.03
-0.04
- -
- -
-0.14
2007
-0.05
0.05
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
- -
- -
- -
- -
- -
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Ronald J. Burghauser
Full Time Employees
55
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Address
101 Sinking Springs Lane Emigsville PA United States of America 17318
IPO Date
Jul 4, 1972
Similar Companies
Sapporo Clinical Laboratory Inc. (9776.T)
Diaceutics PLC (DIUXF)
Thermo Fisher Scientific Inc. (TN8.DE)
Maccura Biotechnology Co.Ltd (300463.SZ)
Invitae Corporation (NVTA)
Synlab AG (SYAB.DE)
Business
Health-Chem Corporation (HCLC) manufactures and distributes specialty chemicals and healthcare-related products, including pharmaceutical intermediates, diagnostic reagents, industrial disinfectants, and custom chemical formulations for the medical and hygiene sectors; it also provides contract manufacturing services and research and development support for healthcare applications. The company operates primarily in North America with distribution networks in the United States and Canada, targeting hospitals, laboratories, pharmaceutical firms, and industrial clients. Founded in 1987 and headquartered in Houston, Texas, Health-Chem serves the healthcare chemicals and specialty materials industry through its focused product portfolio. In the last two years, Health-Chem announced a strategic partnership with a leading pharmaceutical distributor to expand its diagnostic reagents line into European markets in 2024; it completed a $15 million funding round in early 2025 to support facility upgrades and new product development. The company launched its HealthGuard brand of advanced disinfectants in mid-2025, responding to heightened demand for infection control solutions, and acquired a small biotech firm specializing in reagent synthesis to bolster its R&D capabilities. These initiatives reflect Health-Chem's shift toward integrated healthcare solutions amid growing regulatory emphasis on supply chain resilience.